GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (WAR:SPH) » Definitions » EBIT per Share

Sopharma AD-Sofia (WAR:SPH) EBIT per Share : zł1.50 (TTM As of Jun. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Sopharma AD-Sofia EBIT per Share?

Sopharma AD-Sofia's EBIT per Share for the three months ended in Jun. 2024 was zł0.25. Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 was zł1.50.

During the past 12 months, the average EBIT per Share Growth Rate of Sopharma AD-Sofia was -36.50% per year. During the past 3 years, the average EBIT per Share Growth Rate was 16.10% per year. During the past 5 years, the average EBIT per Share Growth Rate was 13.10% per year. During the past 10 years, the average EBIT per Share Growth Rate was 3.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Sopharma AD-Sofia's EBIT per Share or its related term are showing as below:

WAR:SPH' s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: -9.3   Med: 2.8   Max: 16.1
Current: 16.1

During the past 13 years, the highest 3-Year average EBIT per Share Growth Rate of Sopharma AD-Sofia was 16.10% per year. The lowest was -9.30% per year. And the median was 2.80% per year.

WAR:SPH's 3-Year EBIT Growth Rate is ranked better than
76.29% of 97 companies
in the Medical Distribution industry
Industry Median: 3 vs WAR:SPH: 16.10

Sopharma AD-Sofia's EBIT for the three months ended in Jun. 2024 was zł49 Mil.


Sopharma AD-Sofia EBIT per Share Historical Data

The historical data trend for Sopharma AD-Sofia's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia EBIT per Share Chart

Sopharma AD-Sofia Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBIT per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.73 0.76 1.89 1.59 1.91

Sopharma AD-Sofia Quarterly Data
Jun19 Sep19 Dec19 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBIT per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.66 0.32 0.31 0.62 0.25

Sopharma AD-Sofia EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Sopharma AD-Sofia's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

EBIT per Share(A: Dec. 2023 )
=EBIT/Shares Outstanding (Diluted Average)
=264.973/139.097
=1.90

Sopharma AD-Sofia's EBIT per Share for the quarter that ended in Jun. 2024 is calculated as

EBIT per Share(Q: Jun. 2024 )
=EBIT/Shares Outstanding (Diluted Average)
=49.304/199.706
=0.25

EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł1.50

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sopharma AD-Sofia  (WAR:SPH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.


Sopharma AD-Sofia EBIT per Share Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Sopharma AD-Sofia Business Description

Traded in Other Exchanges
Address
5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756
Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are the Production of pharmaceutical products; Distribution of pharmaceutical products; and Others. It generates the majority of its revenue from the Distribution of pharmaceutical products.